Xencor, Inc. (XNCR)
Publicly reported company facts and saved market data for Xencor, Inc. (XNCR), with sources and as-of times. Saved data is not a live quote.
Company profile
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and multiple XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.2B · as of
- Incorporated in
- United States
- Company website
- www.xencor.com
- Exchange
- NASDAQ
FennEdge notes
Sessions where XNCR appeared in the Small-Cap Daily, newest first: opening gap, day change and the SEC filing or halt stored by the close. Facts with source links.
- #7 top gapper · gap +28.32% · closed +15.89% 8-K Earnings 3 Today's Agenda XmAb819 development strategy Updated Phase 1 results of XmAb819, a novel ENPP3 x CD3 bispecific, in advanced clear cell renal cell carcinoma (ccRCC) Overview & XmAb® 2+1 T-cell Engagers Summary and Q&A Additional results
Related articles
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $30.1
- Reported change
- +3.05%
- Reported volume
- 1,289,581
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float F01 | 72,256,631 | Reported by a single source; not cross-checked. | |
| Historical float F02 | 1,001,689 | Historical estimate from the SEC-disclosed public float value; not current tradable shares. | |
| Shares outstanding (O/S) | 74,353,397 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Short interest
- Reported short interest
- 12,266,541 shares
- Settlement date
- Source
- Market and company data
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 32.31 | 33.60 | 28.84 | 29.18 | 8,902,707 | |
| 25.52 | 25.81 | 24.42 | 25.18 | 1,458,064 | |
| 25.18 | 26.12 | 24.71 | 25.84 | 936,348 | |
| 25.40 | 25.50 | 24.42 | 25.16 | 1,479,582 | |
| 23.25 | 25.01 | 23.25 | 24.94 | 884,203 | |
| 22.99 | 23.49 | 21.97 | 23.19 | 2,036,701 | |
| 24.02 | 24.21 | 22.76 | 22.85 | 1,129,982 | |
| 23.14 | 24.30 | 23.14 | 24.00 | 726,920 | |
| 23.43 | 24.26 | 23.21 | 23.39 | 1,369,922 | |
| 25.00 | 25.16 | 23.33 | 23.52 | 2,425,957 |
Dilution timeline
As of
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue